Biocartis

Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary Idylla^TM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer.

Biocartis’ proprietary molecular diagnostics (MDx) Idylla^TM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting, allowing fast and effective treatment selection and treatment progress monitoring.

Biocartis is headquartered in Mechelen, Belgium.